Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Retained Earnings (2011 - 2026)

Verastem (VSTM) posted quarterly Retained Earnings of -$1.2 billion for Q1 2026, down 19.25% year-over-year from -$1.5 billion in Q1 2025, and down 3.14% quarter-over-quarter from -$1.2 billion in Q4 2025.

Analysis

Verastem (VSTM) Retained Earnings (2011 - 2026) Analysis & Trends

Verastem's Retained Earnings history runs 16 years deep, the most recent figure standing at -$1.2 billion for Q1 2026.

  • In Q1 2026, Retained Earnings fell 19.25% year-over-year to -$1.2 billion; the TTM figure through Mar 2026 stood at -$1.2 billion (down 19.25% YoY), while the FY2025 annual figure was -$1.2 billion, down 21.92% from the prior year.
  • Retained Earnings for Q1 2026 stood at -$1.2 billion, down from -$1.2 billion in the prior quarter.
  • The five-year high for Retained Earnings was -$4000.0 in Q1 2024, with the low at -$1.2 billion in Q1 2026.
  • The 5-year median for Retained Earnings is -$824.9 million (2023), against an average of -$838.1 million.
  • The sharpest annual moves came in 2024 and 2025: Retained Earnings surged 100.0% in 2024, then slumped 25190650.0% in 2025.
  • Verastem's Retained Earnings stood at -$737.5 million in 2022, then decreased by 11.85% to -$824.9 million in 2023, then fell by 15.84% to -$955.5 million in 2024, then slipped by 21.92% to -$1.2 billion in 2025, then decreased by 3.14% to -$1.2 billion in 2026.
  • Business Quant data shows VSTM's Retained Earnings at -$1.2 billion in Q1 2026, -$1.2 billion in Q4 2025, and -$1.1 billion in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn -1.24 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.24 Bn
Mar 31, 2026 -1.20 Bn
Dec 31, 2025 -1.16 Bn
Sep 30, 2025 -1.13 Bn
Jun 30, 2025 -1.03 Bn
Mar 31, 2025 -1.01 Bn
Dec 31, 2024 -955.53 Mn
Sep 30, 2024 -890.98 Mn
Jun 30, 2024 -867.01 Mn
Mar 31, 2024 -858.75 Mn
Dec 31, 2023 -824.89 Mn
Sep 30, 2023 -797.52 Mn
Jun 30, 2023 -777.52 Mn
Mar 31, 2023 -753.24 Mn
Dec 31, 2022 -737.52 Mn
Sep 30, 2022 -720.72 Mn
Jun 30, 2022 -702.63 Mn
Mar 31, 2022 -680.70 Mn
Dec 31, 2021 -663.71 Mn
Sep 30, 2021 -647.23 Mn